The iShares S&P 500 Health Care Sector UCITS ETF is an exchange-traded fund that tracks the S&P 500 Capped 35/20 Health Care Index, comprising U.S. companies in the health care sector as defined by the Global Industry Classification Standard. Launched on November 20, 2015, and domiciled in Ireland, this accumulating ETF reinvests dividends, with a low total expense ratio of 0.15% per annum and a fund size exceeding EUR 2.3 billion. It employs physical replication through a long-only strategy, maintaining currency unhedged exposure to USD-denominated assets. Key holdings include leading firms like Eli Lilly and Company (around 15%), Johnson & Johnson (about 9%), AbbVie, UnitedHealth Group, and Merck, representing pharmaceuticals, biotechnology, health care providers, and equipment manufacturers. As a UCITS-compliant product managed by iShares (BlackRock), it adheres to strict EU regulations ensuring diversification—no single holding exceeds 10% of net asset value—liquidity, transparency, independent custody, and limited leverage, making it suitable for retail investors across Europe. This ETF provides targeted access to the resilient health care industry, a vital segment of the broader U.S. equity market influencing innovation in medical treatments, services, and technology.